Mia Femtech 乳房协调术100例前瞻性研究3年安全性及有效性结果
这项3年前瞻性对照研究纳入100例受试者,经腋窝切口行胸肌前假体放置的微创乳房协调术,评估安全性和有效性。3年时75.3%受试者罩杯增加1至3个罩杯,Kaplan-Meier累积并发症率为3.2%,随访依从性93%,未见感觉丧失、包膜挛缩(Baker III/IV级)或BIA-ALCL等报告。
要点
- 3年时75.3%受试者罩杯增加1至3个罩杯。
- 3年Kaplan-Meier累积并发症率为3.2%,再手术率低。
- 未报告乳头或乳房感觉丧失、假体破裂或BIA-ALCL。
核心结论
- 该微创乳房协调术3年并发症率低、恢复快且患者满意度提升。
研究设计与样本
- 3年前瞻性对照研究,IRB批准,纳入100例受试者,经腋窝切口行胸肌前假体放置。
- 安全性通过定期访视监测术后并发症累积发生率,并在33例随机亚组中以MRI评估。
主要发现
- 3年有效性终点报告75.3%受试者罩杯增加1至3个罩杯。
- 3年总体Kaplan-Meier并发症率为3.2%,再手术率低,随访依从性93%。
- 未报告乳头或乳房感觉丧失、切口相关并发症、假体破裂、包膜挛缩(Baker III/IV级)、感染、血清肿、波纹、血肿或BIA-ALCL。
关键数值与推荐
- 3年罩杯增加1至3个罩杯的比例为75.3%。
- 3年总体Kaplan-Meier并发症率为3.2%。
- 随访依从性为93%。
- 证据等级:4(治疗性)。
临床怎么用
- 该术式可作为乳房增强的微创组织保留选项,需关注长期并发症监测与患者选择。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Conventional breast augmentation using different approaches and implant pockets faces challenges such as societal stigma, long recovery time, invasion of the breast, and complication rates. Previous minimally invasive approaches have failed to provide long-term safety, effectiveness, and patient satisfaction. The authors of this study introduce a minimally invasive breast harmonization procedure, performed with an inflatable balloon and a biconvex-shaped silicone-filled implant, addressing these limitations with a safe and innovative solution. OBJECTIVES: In this prospective controlled study, the authors evaluate the safety and effectiveness of this procedure, reducing surgical complications while providing a new treatment option for breast enhancement. METHODS: A 3-year, IRB-approved study enrolled 100 participants undergoing this procedure, utilizing an axillary incision with prepectoral implant placement. Safety was assessed by monitoring the cumulative incidence of postoperative complications in scheduled visits and with MRI evaluations in a randomized subcohort (33 participants). Patient satisfaction was measured pre- and postprocedure using Breast-Q questionnaires and scar evaluation with the Patient and Observer Scar Assessment Scale. RESULTS: Effectiveness endpoint at 3 years reported a 75.3% bra increase of 1 to 3 cup sizes. The overall Kaplan-Meier complication rate at 3 years was 3.2%, with low reoperation rates and 93% follow-up compliance. There were no patient reports of nipple or breast sensitivity loss, nor surgeon-reported incision-related complications, implant rupture, capsular contracture (Baker Grade III/IV), infection, seroma, rippling, hematoma, or breast implant-associated anaplastic large cell lymphoma. CONCLUSIONS: This study demonstrates very low complication rates, faster recovery, and enhanced patient satisfaction with this procedure compared with conventional breast augmentation. Its minimally invasive tissue-preservation approach introduces new surgical concepts, advancing surgical techniques and technologies beyond conventional methods. LEVEL OF EVIDENCE: : 4 (Therapeutic).
引用
- Chacon-Quiros M, Sforza M, Solis-Chaves P, et al. The 3-Year Results of a 100-Patient Prospective Study of the Safety and Effectiveness of Mia Femtech. Aesthet Surg J. 2026. PMID: 41052824. doi:10.1093/asj/sjaf196
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。